Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection

BACKGROUND: The capacity of cytomegalovirus (CMV) to elicit long-lasting strong T cell responses, and the ability to engineer the genome of this DNA virus positions CMV-based vaccine vectors highly suitable as a cancer vaccine platform. Defined immune thresholds for tumor protection and the factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyranvand Nejad, Elham, Ratts, Robert B., Panagioti, Eleni, Meyer, Christine, Oduro, Jennifer D., Cicin-Sain, Luka, Früh, Klaus, van der Burg, Sjoerd H., Arens, Ramon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357411/
https://www.ncbi.nlm.nih.gov/pubmed/30704520
http://dx.doi.org/10.1186/s40425-019-0500-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357411/
https://www.ncbi.nlm.nih.gov/pubmed/30704520
http://dx.doi.org/10.1186/s40425-019-0500-9

Ejemplares similares